Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?

Fertility and Sterility

Volumn 103, Issue 6, 2015, Pages 1477-1484.e5

  Hill, Micah J ^a,b   Royster, Greene Donald ^a,b   Healy, Mae Wu ^a,b   Richter, Kevin S ^a   Levy, Gary ^a,b   Decherney, Alan H ^b   Levens, Eric D ^a   Suthar, Geeta ^a   Widra, Eric ^a   Levy, Michael J ^a  

^a Shady Grove Fertility   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Elevated progesterone; implantation; IVF; premature luteinization

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE; BIOLOGICAL MARKER; FERTILITY PROMOTING AGENT;

AGE; ARTICLE; BLASTOCYST; CELL PROTECTION; CRYOPRESERVATION; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; MAJOR CLINICAL STUDY; OOCYTE MATURATION; PATIENT ATTITUDE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGNOSIS; RETROSPECTIVE STUDY; ADULT; BLOOD; COHORT ANALYSIS; DRUG EFFECTS; INFERTILITY, FEMALE; MIDDLE AGED; OOCYTE; OOCYTE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; UPREGULATION; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; COHORT STUDIES; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; MARYLAND; MIDDLE AGED; OOCYTES; OOGENESIS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 84930926983     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.02.038     Document Type: Article

References (32)

1. M. Al-Azemi, D. Kyrou, E.M. Kolibianakis, P. Humaidan, I. Van Vaerenberg, and P. Devroey Elevated progesterone during ovarian stimulation for IVF Reprod Biomed Online 24 2012 381 388
2. F. Olivennes, J. Belaisch-Allart, J.C. Emperaire, H. Dechaud, S. Alvarez, and L. Moreau Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin) Fertil Steril 73 2000 314 320
3. L.G. Westergaard, K. Erb, S.B. Laursen, S. Rex, and P.E. Rasmussen Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study Fertil Steril 76 2001 543 549
4. J.S. Younis "Premature luteinization" in the era of GnRH analogue protocols: time to reconsider J Assist Reprod Genet 28 2011 689 692
5. E. Bosch, E. Labarta, J. Crespo, C. Simon, J. Remohi, and J. Jenkins Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles Hum Reprod 25 2010 2092 2100
6. M.C. Edelstein, H.J. Seltman, B.J. Cox, S.M. Robinson, R.A. Shaw, and S.J. Muasher Progesterone levels on the day of human chorionic-gonadotropin administration in cycles with gonadotropin-releasing-hormone agonist suppression are not predictive of pregnancy outcome Fertil Steril 54 1990 853 857
7. K.M. Silverberg, M. Martin, D.L. Olive, W.N. Burns, and R.S. Schenken Elevated serum progesterone levels on the day of human chorionic-gonadotropin administration in in-vitro fertilization cycles do not adversely affect embryo quality Fertil Steril 61 1994 508 513
8. R. Ochsenkuhn, A. Arzberger, V. von Schonfeldt, J. Gallwas, N. Rogenhofer, and A. Crispin Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers Fertil Steril 98 2012 347 354
9. E.G. Papanikolaou, E.M. Kolibianakis, C. Pozzobon, P. Tank, H. Tournaye, and C. Bourgain Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer Fertil Steril 91 2009 949 952
10. W. Schoolcraft, E. Sinton, T. Schlenker, D. Huynh, F. Hamilton, and D.R. Meldrum Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate Fertil Steril 55 1991 563 566
11. E. Bosch, W. Valencia, E. Escudero, J. Crespo, C. Simon, and J. Remohi Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Fertil Steril 80 2003 1444 1449
12. F. Ubaldi, J. Smitz, A. Wisanto, H. Joris, J. Schiettecatte, and M.P. Derde Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone Hum Reprod 10 1995 3091 3096
13. F. Martinez, B. Coroleu, E. Clua, R. Tur, R. Buxaderas, and N. Parera Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles Reprod Biomed Online 8 2004 183 190
14. C.A. Venetisi, E.M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, and B.C. Tarlatzis Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis Hum Reprod Update 13 2007 343 355
15. R. Lahoud, M. Kwik, J. Ryan, M. Al-Jefout, J. Foley, and P. Illingworth Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality Arch Gynecol Obstet 285 2012 535 540
16. E.M. Kolibianakis, C.A. Venetis, J. Bontis, and B.C. Tarlatzis Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis Curr Pharm Biotechnol 13 2011 464 470
17. R.J. Stillman, K.S. Richter, N.K. Banks, and J.R. Graham Elective single embryo transfer: a 6-year progressive implementation of 784 single blastocyst transfers and the influence of payment method on patient choice Fertil Steril 92 2009 1895 1906
18. A.P. Ferratti, A. La Marca, B.C. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum Reprod 26 2011 1616 1624
19. R.G. Steward, L. Lan, A.A. Shah, J.S. Yeh, T.M. Price, J.M. Godlfarb, and S.J. Muasher Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Fertil Steril 101 2014 967 973
20. G. Griesinger, B. Mannaerts, C.Y. Andersen, H. Witjes, E.M. Kolibianakis, and K. Gordon Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials Fertil Steril 100 2013 1622 1628
21. E. Bosch Does progesterone elevation compromise pregnancy rates in high responders? Insufficient evidence to draw a conclusion Fertil Steril 101 2013 e3 e4
22. E. Kolibianakis, C. Bourgain, C. Albano, K. Osmanagaoglu, J. Smitz, and A. Van Steirteghem Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up Fertil Steril 78 2002 1025 1029
23. R. Fanchin, C. Righini, F. Olivennes, J. Taieb, D. de Ziegler, and R. Frydman Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation Fertil Steril 71 1999 174 181
24. I. Van Vaerenbergh, H.M. Fatemi, C. Blockeel, L. Van Lommel, P. In't Veld, and F. Schuit Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression Reprod Biomed Online 22 2011 263 271
25. R. Li, J. Qiao, L.N. Wang, L. Li, X.M. Zhen, and P. Liu MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration Reprod Biol Endocrinol 9 2011 29
26. E. Labarta, J.A. Martinez-Conejero, P. Alama, J.A. Horcajadas, A. Pellicer, and C. Simon Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis Hum Reprod 26 2011 1813 1825
27. R. Fanchin, A. Hourvitz, F. Olivennes, J. Taieb, A. Hazout, and R. Frydman Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture Fertil Steril 68 1997 648 652
28. R. Fanchin, C. Righini, F. Olivennes, D. deZiegler, J. Selva, and R. Frydman Premature progesterone elevation does not alter oocyte quality in in vitro fertilization Fertil Steril 65 1996 1178 1183
29. R. Fanchin, C. Righini, F. Olivennes, A.L. Ferreira, D. deZiegler, and R. Frydman Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy Fertil Steril 68 1997 799 805
30. M.A. Melo, M. Meseguer, N. Garrido, E. Bosch, A. Pellicer, and J. Remohi The significance of premature luteinization in an oocyte-donation programme Hum Reprod 21 2006 1503 1507
31. P.E. Patton, J.Y. Lim, L.R. Hickok, M. Kettel, J.M. Larson, and K.Y. Pau Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in vitro fertilization Fertil Steril 101 2014 1629 1636
32. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, C. Hudson, and S. Thomas Embryo cryopreservation rescues cycles with premature luteinization Fertil Steril 93 2010 636 641